{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-314214","form_type":"8-K","ticker":"SMMT","cik":"0001599298","company_name":"Summit Therapeutics Inc.","filed_at":"2026-07-23T20:34:53+00:00","discovered_at":"2026-07-23T20:36:00.525714+00:00","generated_at":"2026-07-23T20:36:16.782868+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Summit Therapeutics enters $380M at-the-market equity distribution agreement with J.P. Morgan","bullets":["Up to $380M of common stock may be sold through J.P. Morgan as sales agent.","Sales agent commission up to 3.0% of gross sales price per share sold.","Company not obligated to sell any shares; may suspend solicitations at any time.","Sales may be made at market prices on Nasdaq or in block transactions.","Prospectus supplement filed July 23, 2026; shares offered under existing S-3."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-314214","json":"https://secwatch.observer/filing/0001193125-26-314214.json","markdown":"https://secwatch.observer/filing/0001193125-26-314214.md","text":"https://secwatch.observer/filing/0001193125-26-314214.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1599298/000119312526314214/0001193125-26-314214-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1599298/000119312526314214/d143170d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-23T20:36:16.782868+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}